tradingkey.logo
tradingkey.logo
Search

Lilly To Acquire Kelonia Therapeutics To Advance In Vivo Car-T Cell Therapies

ReutersApr 20, 2026 1:01 PM
facebooktwitterlinkedin

Eli Lilly and Co LLY.N:

  • LILLY TO ACQUIRE KELONIA THERAPEUTICS TO ADVANCE IN VIVO CAR-T CELL THERAPIES

  • ELI LILLY - UNDER TERMS OF AGREEMENT, LILLY WILL ACQUIRE KELONIA, AND KELONIA SHAREHOLDERS WILL RECEIVE UP TO $7.00 BILLION IN CASH

  • ELI LILLY: TRANSACTION IS EXPECTED TO CLOSE IN SECOND HALF OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI